JOHNSON & JOHNSON

JNJ
Delayed Quote. Delayed  - 09/25 04:10:00 pm
145.66USD +0.68%
Prev.144.6700
Open144.0000
High146.2500
Low143.8900
Volume5 614 844
Latest news
16h ago
17h ago
18h ago
2d ago
Chart JOHNSON & JOHNSON
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBullish
Resistance149156155
Spread/Res.-2,4%-6,3%-5,9%
Spread/Supp.1,0%13%7,1%
Support144129136
Financials
Sales 2020 80 541 M - -
Net income 2020 16 242 M - -
Net Debt 2020 3 827 M - -
P/E ratio 2020 23,9x
Yield 2020 2,75%
Capitalization 383 B 383 B -
EV / Sales 2020 4,81x
EV / Sales 2021 4,30x
Nbr of Employees 132 200
Free-Float 84,3%
Company
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (51.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, immunological,...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2020-10-13 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 162,89 $
Last Close Price 145,66 $
Spread / Highest target 23,6%
Spread / Average Target 11,8%
Spread / Lowest Target -3,20%